Viewing Study NCT02517866

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2026-06-27 @ 5:37 AM
Study NCT ID: NCT02517866
Status: COMPLETED
Last Update Posted: 2019-03-01
First Post: 2015-06-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
Sponsor: Takeda
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Essential Hypertension View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View